经尺动脉介入化疗治疗晚期及术后复发乳腺癌的临床研究  

Clinical study of trans-ulner artery approach chemotherapy in the treatment of late and postoperative recurrent breast cancer

作　　者：李一平 杨迪 

机构地区：[1]兰州市第一人民医院放射科,甘肃兰州730050

出　　处：《中国现代医生》2016年第33期78-80,共3页China Modern Doctor

摘　　要：目的探讨经尺动脉介入化疗治疗晚期及术后复发乳腺癌的临床效果。方法选取2014年5月~2016年2月期间就诊的晚期乳腺癌及术后复发乳腺癌患者50例,所有患者均给予尺动脉介入化疗治疗,分析其临床治疗效果。结果通过介入化疗治疗后患者完全缓解和部分缓解合计构成比为86.00%,显著高于病情稳定及病情进展患者的构成比14.00%;患者出现不同程度的恶心、呕吐、食欲不振等并发症,其中恶心、呕吐的比例明显高于其他并发症。结论介入化疗治疗晚期乳腺癌及复发性乳腺癌虽然会导致一定的并发症,但是其治疗的效果是肯定的,能明显改善治疗效果。Objective To investigate the clinical effect of trans-ulner artery chemotherapy in the treatment of late and postoperative recurrent breast cancer. Methods A total of 50 patients with late and postoperative recurrent breast cancer who were treated from May 2014 to February 2016 were selected by numeration table. All patients were given trans-ulner artery chemotherapy and the clinical effects were analyzed. Results The ratio of complete released and part released patients after interventional chemotherapy was 86.00%, significantly higher than the ratio of stable and progressed patients（14.00%）; the patients had complications of different degree like nausea, vomiting and inappetence and nausea and vomiting was obviously higher than the other complications. Conclusion Although interventional chemotherapy in the treatment of late and recurrent breast cancer patients can lead complications, the clinical effect is positive and improves the treatment effect significantly.

关 键 词：复发乳腺癌 尺动脉介入化疗 晚期乳腺癌 术后复发乳腺癌 

分 类 号：R737.9[医药卫生—肿瘤]